计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| A649234-5mg |
5mg |
期货 ![]() |
| |
| A649234-10mg |
10mg |
期货 ![]() |
| |
| A649234-25mg |
25mg |
期货 ![]() |
| |
| A649234-50mg |
50mg |
期货 ![]() |
| |
| A649234-100mg |
100mg |
期货 ![]() |
|
| 别名 | 安多斯特游离碱 |
|---|---|
| 英文别名 | Andolast | SCHEMBL166170 | 6513M33209 | HY-106358 | Cr2039 | CR 2039 | UNII-6513M33209 | Benzamide, 4-(2H-tetrazol-5-yl)-N-[4-(2H-tetrazol-5-yl)phenyl]- | Andolast [INN] | DTXSID80157682 | 4-(2H-tetrazol-5-yl)-N-[4-(2H-tetrazol-5-yl)phenyl]benzamide | Q27 |
| 规格或纯度 | ≥98% |
| 英文名称 | Andolast free base |
| 生化机理 | 安多司特(CR 2039)(游离碱)是一种抗过敏药。安多司特可抑制 cAMP 磷酸二酯酶,IC50 值为 50 μM。安多司特可用于哮喘研究。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 激活剂 |
| 作用机制 | 钙激活钾通道亚基 alpha-1 激活剂 |
| 产品介绍 |
Andolast (CR 2039) (free base) is an anti-allergic agent. Andolast can inhibit cAMP-phosphodiesterase with an IC 50 value of 50 μM. Andolast can be used for the research of asthma. In Vivo Andolast (CR 2039) (i.v. or i.m.) inhibits rat passive cutaneous anaphylaxis (PCA) with an ED 50 of 0.1 mg/kg . CR 2039 (10-100 mg/kg; i.v. or i.m.) inhibits the microvascular permeability changes in a model of allergic conjunctivitis in sensitized guinea-pigs . CR 2039 (0-1000 μM; i.v.) inhibits dose dependently guinea-pig lung cAMP-phosphodiesterase with an IC 50 value of 50 μM . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Male Hartley guinea-pigs (300-500 g) Dosage: 10-100 mg/kg Administration: I.M; I.V. Result: Showed dose-related significant protection against lgE-dependent bronchial anaphylaxis induced by aerosolized antigen in anesthetized guinea-pigs. Delayed dose dependently the onset of bronchoconstriction induced by aerosolized antigen. Form:Solid |
| 纯度 | ≥98% |
| ALogP | 1.2 |
|---|
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | 4-(2H-tetrazol-5-yl)-N-[4-(2H-tetrazol-5-yl)phenyl]benzamide |
| INCHI | 1S/C15H11N9O/c25-15(11-3-1-9(2-4-11)13-17-21-22-18-13)16-12-7-5-10(6-8-12)14-19-23-24-20-14/h1-8H,(H,16,25)(H,17,18,21,22)(H,19,20,23,24) |
| InChi Key | VXEBMQZDPONDFB-UHFFFAOYSA-N |
| Smiles | C1=CC(=CC=C1C2=NNN=N2)C(=O)NC3=CC=C(C=C3)C4=NNN=N4 |
| Isomeric SMILES | C1=CC(=CC=C1C2=NNN=N2)C(=O)NC3=CC=C(C=C3)C4=NNN=N4 |
| PubChem CID | 65970 |
| 分子量 | 333.31 |
| 溶解性 | DMSO : 50 mg/mL (150.01 mM; ultrasonic and warming and heat to 60°C) |
|---|---|
| 分子量 | 333.310 g/mol |
| XLogP3 | 1.200 |
| 氢键供体数Hydrogen Bond Donor Count | 3 |
| 氢键受体数Hydrogen Bond Acceptor Count | 7 |
| 可旋转键计数Rotatable Bond Count | 4 |
| 精确质量Exact Mass | 333.109 Da |
| 单同位素质量Monoisotopic Mass | 333.109 Da |
| 拓扑极表面积Topological Polar Surface Area | 138.000 Ų |
| 重原子数Heavy Atom Count | 25 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 448.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |